DUBLIN and SAN JOSE, Calif., Oct. 30, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced the U.S. launch of its advanced Patient Programmer technology for Deep Brain Stimulation (DBS) ...

DUBLIN - Medtronic plc today announced that the company has received U.S. Food and Drug Administration (FDA) approval for the CareLink SmartSync(TM) Device Manager. With the introduction of SmartSync, ...

The medical device giant has issued fixes for bugs first disclosed in 2018 and 2019. Medtronic has released updates to address known vulnerabilities in its line of connected medical devices that were ...

Medtronic plc MDT recently announced favorable data from its study on MARVEL 2 (Micra Atrial Tracking Using A Ventricular accELerometer). The study results demonstrate that an investigational set of ...

CRT Innovation is the First to Offer Exclusive OptiVol® Fluid Status Monitoring with Complete Remote Follow-Up for Proactive Heart Failure Management “Atrial arrhythmias are the number one cause of ...

Ohio State University’s Wexner Medical Center was recently the first hospital in the world to use technology that reduces the number of people in the operating room for pacemaker surgeries. The ...

When Earl Bakken started Medtronic back in 1949, little did he realize that his pioneering work in electrical heart pacemakers would spawn a vast industry whose devices would save millions of lives ...

DUBLIN, Jan. 5, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has received CE (Conformité Européenne) Mark for its Micra™ AV2 and Micra™ ...

The first unexpected power failure in a Medtronic InSync III pacemaker didn't set off the alarm bells. But by the fourth time, doctors at the Minneapolis Heart Institute knew they had to act quickly.

The FDA has approved Medtronic plc's (NYSE:MDT) Micra AV2 and Micra VR2, the next generation of its miniaturized, leadless pacemakers. The company says Micra AV2 and Micra VR2, the world's smallest ...